2023 Q3 Form 10-Q Financial Statement

#000093041323002074 Filed on September 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $212.0M
YoY Change -11.8%
Cost Of Revenue $193.6M
YoY Change -13.46%
Gross Profit $18.35M
YoY Change 10.66%
Gross Profit Margin 8.66%
Selling, General & Admin $8.618M
YoY Change -5.79%
% of Gross Profit 46.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.495M
YoY Change -0.66%
% of Gross Profit 24.49%
Operating Expenses $8.618M
YoY Change -5.79%
Operating Profit $9.734M
YoY Change 30.9%
Interest Expense $3.047M
YoY Change -15.31%
% of Operating Profit 31.3%
Other Income/Expense, Net $3.271M
YoY Change -60.02%
Pretax Income $16.05M
YoY Change -16.46%
Income Tax $3.768M
% Of Pretax Income 23.47%
Net Earnings $9.055M
YoY Change -18.93%
Net Earnings / Revenue 4.27%
Basic Earnings Per Share $0.52
Diluted Earnings Per Share $0.52
COMMON SHARES
Basic Shares Outstanding 17.50M shares
Diluted Shares Outstanding 17.46M shares

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $284.4M
YoY Change 16.02%
Cash & Equivalents $102.2M
Short-Term Investments $182.2M
Other Short-Term Assets $1.536M
YoY Change -91.39%
Inventory $45.96M
Prepaid Expenses
Receivables $32.00M
Other Receivables $5.654M
Total Short-Term Assets $387.9M
YoY Change 8.57%
LONG-TERM ASSETS
Property, Plant & Equipment $135.1M
YoY Change 2.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.58M
YoY Change 4.06%
Other Assets $19.55M
YoY Change -10.92%
Total Long-Term Assets $205.0M
YoY Change 1.21%
TOTAL ASSETS
Total Short-Term Assets $387.9M
Total Long-Term Assets $205.0M
Total Assets $592.9M
YoY Change 5.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.10M
YoY Change 4.27%
Accrued Expenses $20.35M
YoY Change 24.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.54M
YoY Change 13.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $3.144M
YoY Change 6.25%
Total Long-Term Liabilities $11.85M
YoY Change -18.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.54M
Total Long-Term Liabilities $11.85M
Total Liabilities $59.39M
YoY Change 5.24%
SHAREHOLDERS EQUITY
Retained Earnings $655.1M
YoY Change 4.07%
Common Stock $3.480M
YoY Change 1063.88%
Preferred Stock
YoY Change
Treasury Stock (at cost) $192.0M
YoY Change 2.7%
Treasury Stock Shares
Shareholders Equity $466.6M
YoY Change
Total Liabilities & Shareholders Equity $592.9M
YoY Change 5.91%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income $9.055M
YoY Change -18.93%
Depreciation, Depletion And Amortization $4.495M
YoY Change -0.66%
Cash From Operating Activities $19.26M
YoY Change 4.41%
INVESTING ACTIVITIES
Capital Expenditures $3.974M
YoY Change -369.61%
Acquisitions
YoY Change
Other Investing Activities $7.839M
YoY Change -134.4%
Cash From Investing Activities $3.865M
YoY Change -115.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 19.26M
Cash From Investing Activities 3.865M
Cash From Financing Activities 0.000
Net Change In Cash 23.13M
YoY Change -269.64%
FREE CASH FLOW
Cash From Operating Activities $19.26M
Capital Expenditures $3.974M
Free Cash Flow $15.29M
YoY Change -23.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-09097
dei Entity Registrant Name
EntityRegistrantName
REX AMERICAN RESOURCES CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-1095548
dei Entity Address Address Line1
EntityAddressAddressLine1
7720 Paragon Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Dayton
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45459
dei City Area Code
CityAreaCode
937
dei Local Phone Number
LocalPhoneNumber
276-3931
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
REX
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17503745 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102166000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69612000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
182209000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
211331000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2009000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1735000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31998000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25162000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
45960000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
48744000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5654000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2962000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17947000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13098000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
387943000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
372644000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135144000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135497000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12713000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15214000 usd
CY2023Q3 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
19554000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
23179000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
37582000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
33045000 usd
CY2023Q3 us-gaap Assets
Assets
592936000 usd
CY2023Q1 us-gaap Assets
Assets
579579000 usd
rex Accounts Payable Related Parties
AccountsPayableRelatedParties
1200000 usd
CY2023 rex Accounts Payable Related Parties
AccountsPayableRelatedParties
1500000 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
22100000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
34091000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5095000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5180000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20346000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15328000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
47541000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54599000 usd
CY2023Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
1097000 usd
CY2023Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
1097000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7605000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9855000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3144000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3034000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11846000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13986000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
299000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
299000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3181000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
578000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
655117000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
640826000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
192037000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
193721000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
466560000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
447982000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
66989000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
63012000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
533549000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
510994000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
592936000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
579579000 usd
CY2023Q3 us-gaap Revenues
Revenues
211977000 usd
CY2022Q3 us-gaap Revenues
Revenues
240328000 usd
us-gaap Revenues
Revenues
424691000 usd
us-gaap Revenues
Revenues
434556000 usd
CY2023Q3 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
26399000 usd
CY2022Q3 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
35319000 usd
us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
59887000 usd
us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
66077000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
193625000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
226225000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
396173000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
408545000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
18352000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
14103000 usd
us-gaap Gross Profit
GrossProfit
28518000 usd
us-gaap Gross Profit
GrossProfit
26011000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8618000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6667000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14387000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11866000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3047000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3598000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4537000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5549000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
3271000 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8181000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
6072000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
8355000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16052000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19215000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24740000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28049000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3768000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4330000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5756000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6178000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
12284000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
14885000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
18984000 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
21871000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
3229000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
3715000 usd
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
4693000 usd
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
5519000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9055000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
11170000 usd
us-gaap Net Income Loss
NetIncomeLoss
14291000 usd
us-gaap Net Income Loss
NetIncomeLoss
16352000 usd
CY2023Q3 rex Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
17460000 shares
CY2022Q3 rex Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
17772000 shares
rex Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
17427000 shares
rex Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
17777000 shares
CY2023Q3 rex Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
0.52
CY2022Q3 rex Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
0.63
rex Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
0.82
rex Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
0.92
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
510994000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
6700000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
716000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
423000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
517401000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
12284000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3864000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
533549000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
487562000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6986000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
44000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
494591000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
14885000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6193000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1632000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1789000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
503440000 usd
us-gaap Profit Loss
ProfitLoss
18984000 usd
us-gaap Profit Loss
ProfitLoss
21871000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8915000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8984000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2671000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2835000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4537000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5549000 usd
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
-3967000 usd
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
-488000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3947000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4153000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3892000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
856000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-205000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6836000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12738000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2784000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7703000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2692000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-779000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5153000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2153000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-12595000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11254000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3019000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1173000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8637000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
771000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8173000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2936000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
194400000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
189988000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
227490000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
25882000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 usd
us-gaap Payments For Deposits
PaymentsForDeposits
20000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24907000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167042000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6193000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-716000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-1633000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-716000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7826000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32828000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-174097000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71347000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232068000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104175000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57971000 usd
rex Non Cash Investing Activities Accrued Capital Expenditures
NonCashInvestingActivitiesAccruedCapitalExpenditures
1029000 usd
rex Non Cash Investing Activities Accrued Capital Expenditures
NonCashInvestingActivitiesAccruedCapitalExpenditures
260000 usd
rex Non Cash Financing Activities Equity Awards Issued
NonCashFinancingActivitiesEquityAwardsIssued
570000 usd
rex Non Cash Financing Activities Equity Awards Issued
NonCashFinancingActivitiesEquityAwardsIssued
563000 usd
rex Non Cash Financing Activities Stock Awards Issued
NonCashFinancingActivitiesStockAwardsIssued
965000 usd
rex Non Cash Financing Activities Stock Awards Issued
NonCashFinancingActivitiesStockAwardsIssued
1539000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
312000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4507000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102166000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54639000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
2009000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
3332000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104175000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57971000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
202548000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
10166000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5769000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
226225000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
14103000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6667000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
408545000 usd
us-gaap Gross Profit
GrossProfit
26011000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11866000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
6400000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1100000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19034000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19034000 usd
CY2023Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
57000 usd
CY2023Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
55000 usd
us-gaap Inventory Write Down
InventoryWriteDown
200000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
700000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0553 pure
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7072000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12695000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7297000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10194000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
31591000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
25855000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
45960000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
48744000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0551 pure
CY2023Q3 us-gaap Revenues
Revenues
211977000 usd
CY2022Q3 us-gaap Revenues
Revenues
240328000 usd
us-gaap Revenues
Revenues
424691000 usd
us-gaap Revenues
Revenues
434556000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1431000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1991000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3192000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3601000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
61000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
271000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
303000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
665000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
1492000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
2262000 usd
us-gaap Lease Cost
LeaseCost
3495000 usd
us-gaap Lease Cost
LeaseCost
4266000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2853000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4477000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2325000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2276000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1846000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
491000 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14268000 usd
CY2023Q3 rex Present Value Discount
PresentValueDiscount
1568000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12700000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q3 us-gaap Commodity Contract Asset Current
CommodityContractAssetCurrent
5673000 usd
CY2023Q3 rex Forward Purchase Contract Liabilities
ForwardPurchaseContractLiabilities
10707000 usd
CY2023Q1 us-gaap Commodity Contract Asset Current
CommodityContractAssetCurrent
80000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
185000 usd
CY2023Q1 rex Forward Purchase Contract Liabilities
ForwardPurchaseContractLiabilities
355000 usd
CY2023Q1 rex Commodity Contract Liability Current
CommodityContractLiabilityCurrent
67000 usd
CY2023Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
422000 usd
CY2023Q3 us-gaap Land And Land Improvements
LandAndLandImprovements
31130000 usd
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
30194000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23784000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23707000 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
303730000 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
299665000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
13162000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
10255000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
371806000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
363821000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
236662000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
228324000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135144000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135497000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18018000 usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
21964000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1536000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1215000 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
19554000 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
23179000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2820000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4428000 usd
CY2023Q3 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
2507000 usd
CY2023Q1 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
4116000 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
530000 usd
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1311000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2463000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1850000 usd
CY2023Q1 rex Commodity Futures
CommodityFutures
67000 usd
CY2023Q3 rex Forward Purchase Contract Liabilities
ForwardPurchaseContractLiabilities
10707000 usd
CY2023Q1 rex Forward Purchase Contract Liabilities
ForwardPurchaseContractLiabilities
355000 usd
CY2023Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
64000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2049000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1255000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1152000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20346000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15328000 usd
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
5673000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
185000 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
10707000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
422000 usd
CY2023Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
2 usd
CY2023Q1 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
1.7 usd
CY2023Q3 rex Gain Loss On Derivative Instruments Net Sales And Revenue
GainLossOnDerivativeInstrumentsNetSalesAndRevenue
0.1 usd
CY2022Q3 rex Gain Loss On Derivative Instruments Net Sales And Revenue
GainLossOnDerivativeInstrumentsNetSalesAndRevenue
-1.5 usd
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0.8 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1.2 usd
CY2023Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.103 pure
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
37582000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
33045000 usd
CY2023Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
17600000 usd
CY2023Q1 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
13000000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
182200000 usd
CY2023Q3 us-gaap Debt Securities Held To Maturity Maturity Within One Year Weighted Average Yield
DebtSecuritiesHeldToMaturityMaturityWithinOneYearWeightedAverageYield
0.051 pure
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
211300000 usd
CY2023Q1 us-gaap Debt Securities Held To Maturity Maturity Within One Year Weighted Average Yield
DebtSecuritiesHeldToMaturityMaturityWithinOneYearWeightedAverageYield
0.039 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
81264 shares
CY2023Q1 rex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue
2320000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
113726 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3945
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
32135 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
896000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
162855 shares
CY2023Q3 rex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue
5369000 usd
rex Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition
P3Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
30167 shares
CY2022Q1 rex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue
773000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70689 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2032
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
18403 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
451000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
82453 shares
CY2022Q3 rex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue
2354000 usd
rex Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition
P3Y
CY2023Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
265000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
529000 usd
CY2022Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
188000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
188000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000744187
CY2023Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
3800000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
4300000 usd
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
5800000 usd
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
6200000 usd
CY2023Q1 rex Unrecognized Tax Benefits And Accrued Interest And Penalties
UnrecognizedTaxBenefitsAndAccruedInterestAndPenalties
19088000 usd
CY2022Q1 rex Unrecognized Tax Benefits And Accrued Interest And Penalties
UnrecognizedTaxBenefitsAndAccruedInterestAndPenalties
16781000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
93000 usd
CY2023Q3 rex Unrecognized Tax Benefits And Accrued Interest And Penalties
UnrecognizedTaxBenefitsAndAccruedInterestAndPenalties
19091000 usd
CY2022Q3 rex Unrecognized Tax Benefits And Accrued Interest And Penalties
UnrecognizedTaxBenefitsAndAccruedInterestAndPenalties
16874000 usd
CY2023Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
250000 usd
CY2023Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
250000 usd
CY2023Q3 rex Capital Projects Remaining Future Payments
CapitalProjectsRemainingFuturePayments
28500000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000930413-23-002074-index-headers.html Edgar Link pending
0000930413-23-002074-index.html Edgar Link pending
0000930413-23-002074.txt Edgar Link pending
0000930413-23-002074-xbrl.zip Edgar Link pending
c106955_10q-ixbrl.htm Edgar Link pending
c106955_ex18.htm Edgar Link pending
c106955_ex31.htm Edgar Link pending
c106955_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
c106955_10q-ixbrl_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rex-20230731.xsd Edgar Link pending
Show.js Edgar Link pending
rex-20230731_def.xml Edgar Link unprocessable
rex-20230731_cal.xml Edgar Link unprocessable
rex-20230731_lab.xml Edgar Link unprocessable
rex-20230731_pre.xml Edgar Link unprocessable